Form 20-F BioNTech SE For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BioNTech (BNTX) PT Lowered to $151 at Truist Securities
March 11, 2025 11:46 AM EDTTruist Securities analyst Asthika Goonewardene lowered the price target on BioNTech (NASDAQ: BNTX) to $151.00 (from $172.00) while maintaining a Buy rating.
The analyst comments "BNTX's reported 4Q24 revenues of 1.19B was ~6% above consensus, but a bigger focus was the FY25 guidance, most notably the significantly... More
Jefferies Reiterates Buy Rating on BioNTech (BNTX)
March 10, 2025 2:23 PM EDTJefferies analyst Akash Tewari reiterated a Buy rating and $149.00 price target on BioNTech (NASDAQ: BNTX).
The analyst comments "Bottom line: BTNX reported an ok Q - Q4 revs ~1.19B vs 1.18B cons & EPS 1.08 vs 0.77 cons driven by lower Opex. That said, BNTX traded down... More
